|
시장보고서
상품코드
2052247
줄기세포은행 시장 : 공급원별, 서비스별, 용도별, 지역별Stem Cell Banking Market, By Source Type, By Service Type, By Application, By Geography |
||||||
줄기세포은행 시장은 2026년에 74억 7,000만 달러로 추정되며, 2033년까지 197억 5,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 14.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 74억 7,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 14.90% | 2033년 시장 규모 예측: | 197억 5,000만 달러 |
줄기세포는 체내의 특정 세포종으로 분화할 수 있는 미분화 생물학적 세포를 말합니다. 이러한 줄기세포를 은행에 보관하면 기증자나 그 가족이 필요로 할 때, 향후 치료 목적으로 보관 및 유지가 용이해집니다. 암, 혈액질환 등 만성질환 치료를 위한 줄기세포 치료에 대한 인식이 높아지면서 줄기세포은행에 대한 수요가 증가하고 있습니다. 여성 건강에 대한 관심 증가와 줄기세포 연구에 대한 대중의 관심 증가가 시장 성장을 견인할 것으로 예상됩니다. 그러나 줄기세포 채취 및 보관 절차에 따른 높은 비용이 시장 성장을 저해할 수 있습니다. 과학기술의 발전은 가까운 미래에 줄기세포은행 분야에서 더 많은 혁신을 촉진할 것으로 예상됩니다.
시장 역학
세계 줄기세포은행 시장의 성장은 주로 암, 혈액질환과 같은 생명을 위협하는 만성질환의 유병률 증가에 의해 주도되고 있습니다. 줄기세포 치료는 이러한 질병에 대한 잠재적인 치료 옵션을 제공합니다. 또한, 전 세계적으로 줄기세포 연구 활동을 촉진하기 위한 민관 투자 증가도 시장 성장을 촉진하고 있습니다. 불임 치료에 대한 여성 건강에 대한 관심이 높아지고 줄기세포 이식 성공률이 높아지면서 줄기세포 뱅킹의 이용이 확대되고 있습니다. 그러나 채취, 가공, 저장, 운송 절차에 소요되는 높은 비용은 시장 성장을 저해할 수 있습니다. 출산 시 제대혈 은행 이용을 촉진하기 위한 정부 및 민간 기관의 인식 개선 캠페인 증가도 시장 성장에 새로운 기회를 제공하고 있습니다. 시장 참여자들은 개선된 줄기세포 처리 및 보존 기술을 개발하기 위해 연구개발(R&D)에 투자하고 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 줄기세포은행 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 본 조사에서 다루는 주요 기업으로는 Stem Cyte, Inc., CRYO-CELL INTERNATIONAL, INC., ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, Transcell Biolife Pvt. Ltd., Cordlife Group Limited, Covis Pharma, CSG Bio 등이 있습니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 라인업 개편, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 세계 줄기세포은행 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 줄기세포은행 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 줄기세포은행 시장 : 채취원별, 2021-2033년
제5장 세계의 줄기세포은행 시장 : 서비스 유형별, 2021-2033년
제6장 세계의 줄기세포은행 시장 : 용도별, 2021-2033년
제7장 세계의 줄기세포은행 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고문헌 및 조사 방법
KSMStem Cell Banking Market is estimated to be valued at USD 7.47 Bn in 2026 and is expected to reach USD 19.75 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.47 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.90% | 2033 Value Projection: | USD 19.75 Bn |
Stem cells are undifferentiated biological cells that are capable of differentiating into specialized cell types in the body. Banking these stem cells facilitates their storage and preservation for future therapeutic use, when required by the donor or related family members. Growing awareness about stem cell therapies for treating chronic conditions such as cancer and blood disorders has boosted demand for stem cell banking. Increasing focus on women's health and rising public interest in stem cell research are expected to drive the market growth. However, high costs associated with stem cell collection and storage procedures may hamper the market growth. Scientific and technological advancements are expected to drive more innovation in stem cell banking in the near future.
Market Dynamics
Global stem cell banking market growth is primarily driven by rising prevalence of life-threatening chronic diseases like cancer and blood disorders. Stem cell therapies offer potential treatment alternatives for such conditions. Increasing public-private investments to encourage stem cell research activities around the world also drives the market growth. Growing women's health concerns regarding fertility preservation and rising success rates of stem cell transplants boosts adoption of stem cell banking. However, high costs of collection, processing, storage, and transportation procedures can hamper the market growth. Rising awareness campaigns by government and private agencies to promote cord blood banking at childbirth also presents new opportunities for market growth. Market players are investing in R&D to develop improved stem cell processing and storage technologies.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global stem cell banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Stem Cyte, Inc., CRYO-CELL INTERNATIONAL, INC., ViaCord, Cord Blood Registry, SmartCells, Inc., LifeCell International Pvt. Ltd., Cryoviva Biotech Pvt. Ltd., Cryo Stemcell, Reliance Life Sciences, Transcell Biolife Pvt. Ltd., Cordlife Group Limited, Covis Pharma, CSG Bio.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global stem cell banking market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell banking market.
Market Segmentation
- By Source Type (Revenue, USD Bn, 2021 - 2033)
- Umbilical Cord Stem Cell
- Cord Blood
- Cord Tissue
- Placenta
- Adult Stem Cell
- Embryonic Stem Cell
- By Service Type (Revenue, USD Bn, 2021 - 2033)
- Collection and Transportation
- Processing
- Analysis
- Storage
- By Application (Revenue, USD Bn, 2021 - 2033)
- Leukemia
- Diabetes
- Lymphoma
- Cerebral Palsy
- Thalassemia
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Stem Cyte, Inc.
- CRYO-CELL INTERNATIONAL, INC.
- ViaCord
- Cordlife Group Limited
- SmartCells, Inc.
- LifeCell International Pvt. Ltd.
- Cryoviva Biotech Pvt. Ltd.
- Cryo Stemcell
- Reliance Life Sciences
- Transcell Biolife Pvt. Ltd.
- Cordlife Group Limited
- Covis Pharma
- CSG Bio
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source Type
- Market Snapshot, By Service Type
- Market Snapshot, By Application
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Epidemiology
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Stem Cell Banking Market, By Source Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Umbilical Cord Stem Cell
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cord Blood
- Cord Tissue
- Placenta
- Adult Stem Cell
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Embryonic Stem Cell
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Stem Cell Banking Market, By Service Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Collection and Transportation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Processing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Storage
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Stem Cell Banking Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Leukemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cerebral Palsy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Thalassemia
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Stem Cell Banking Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Stem Cyte, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CRYO-CELL INTERNATIONAL, INC.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- ViaCord
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cord Blood Registry
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- SmartCells, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LifeCell International Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cryoviva Biotech Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cryo Stemcell
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Reliance Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Transcell Biolife Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cordlife Group Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Covis Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CSG Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Stem Cyte, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
